19 June 2013
Keywords: fda, begins, safety, review, laba, asthma, drugs
Article | 10 March 2008
The US Food and Drug Administration has requested information from makers of long acting beta-2 agonist (LABA) drugs, which are ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 March 2008
© 2013 thepharmaletter.com